tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

OCX Stock Latest News

Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
Press ReleasesOncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
1M ago
OCX
OncoCyte’s New Sales Agreement and Termination of Old Deal
PremiumCompany Announcements
OncoCyte’s New Sales Agreement and Termination of Old Deal
1M ago
8K
OCX
OncoCyte reports Q2 EPS (36c), consensus (56c)
PremiumThe Fly
OncoCyte reports Q2 EPS (36c), consensus (56c)
1M ago
OCX
OncoCyte announces successful GraftAssure beta launch
PremiumThe Fly
OncoCyte announces successful GraftAssure beta launch
1M ago
BIO
OCX
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
PremiumPress Releases
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
2M ago
OCX
OncoCyte files $100M mixed securities shelf
PremiumThe FlyOncoCyte files $100M mixed securities shelf
2M ago
OCX
OncoCyte’s (OCX) Stock Rises With New Diagnostic Product and Promising Partnership.
Premium
Market News
OncoCyte’s (OCX) Stock Rises With New Diagnostic Product and Promising Partnership.
2M ago
OCX
OncoCyte Announces Andrea James as New CFO and Principal Officer
Premium
Company Announcements
OncoCyte Announces Andrea James as New CFO and Principal Officer
3M ago
8K
OCX
Oncocyte Appoints Andrea James as Chief Financial Officer
PremiumPress Releases
Oncocyte Appoints Andrea James as Chief Financial Officer
3M ago
OCX
OncoCyte appoints Andrea James to CFO
PremiumThe Fly
OncoCyte appoints Andrea James to CFO
3M ago
OCX
AXON
OncoCyte Executive Team Receives Significant Salary Increases
PremiumCompany Announcements
OncoCyte Executive Team Receives Significant Salary Increases
4M ago
8K
OCX
OncoCyte announces VitaGraft Kidney data published in NEJM
PremiumThe Fly
OncoCyte announces VitaGraft Kidney data published in NEJM
4M ago
OCX
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
PremiumPress ReleasesFavorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
4M ago
OCX
OncoCyte reports Q1 EPS ($1.13), consensus (67c)
Premium
The Fly
OncoCyte reports Q1 EPS ($1.13), consensus (67c)
4M ago
OCX
OncoCyte files to sell 5.42M shares of common stock for holders
Premium
The Fly
OncoCyte files to sell 5.42M shares of common stock for holders
4M ago
OCX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
OCX
AGEN
OncoCyte Corp Announces Equity Placement and Fundraising Efforts
PremiumCompany Announcements
OncoCyte Corp Announces Equity Placement and Fundraising Efforts
5M ago
8K
OCX
OncoCyte reports Q4 revenue $314,000, consensus $320,000
PremiumThe Fly
OncoCyte reports Q4 revenue $314,000, consensus $320,000
5M ago
OCX
OncoCyte to sell 5.077M shares at $ 2.92 in private placement
PremiumThe Fly
OncoCyte to sell 5.077M shares at $ 2.92 in private placement
5M ago
OCX
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
PremiumPress ReleasesOncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
5M ago
OCX
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
Premium
Press Releases
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
5M ago
OCX
OncoCyte, BioRad to partner on global launch of GraftAssure assay
Premium
The Fly
OncoCyte, BioRad to partner on global launch of GraftAssure assay
5M ago
BIO
OCX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >